Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Scientists identify and repress breast cancer stem cells in mouse tissue

Scientists identify and repress breast cancer stem cells in mouse tissue

Sunitinib may be associated with cardiac toxicity

Sunitinib may be associated with cardiac toxicity

Great-grandparent of all the cells of the blood identified

Great-grandparent of all the cells of the blood identified

Most carriers of Fanconi anemia genes are not at a higher risk of cancer

Most carriers of Fanconi anemia genes are not at a higher risk of cancer

Researchers advance stem cell gene therapy

Researchers advance stem cell gene therapy

Cancer stem cells may be cause of brain tumors

Cancer stem cells may be cause of brain tumors

Bosutinib safe, effective for chronic myelogenous leukemia

Bosutinib safe, effective for chronic myelogenous leukemia

Data confirm Dasatinib's effectiveness in resistant chronic myelogenous leukemia

Data confirm Dasatinib's effectiveness in resistant chronic myelogenous leukemia

Need for education for primary care physicians on rarely seen cancers

Need for education for primary care physicians on rarely seen cancers

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

Patients without advance care plans more likely to die

Patients without advance care plans more likely to die

New test for targeted therapy in acute myeloid leukemia

New test for targeted therapy in acute myeloid leukemia

New drug candidate knocks out resistant form of chronic myeloid leukemia

New drug candidate knocks out resistant form of chronic myeloid leukemia

Anemia drugs linked with leukemic transformation in patients with primary myelofibrosis

Anemia drugs linked with leukemic transformation in patients with primary myelofibrosis

Umbilical cord blood transplant may confer advantages over bone marrow transplant for kids with life-threatening metabolic disorders

Umbilical cord blood transplant may confer advantages over bone marrow transplant for kids with life-threatening metabolic disorders

Vaccine improves event-free survival for leukemia patients

Vaccine improves event-free survival for leukemia patients

New role for miRNA in leukemia discovered

New role for miRNA in leukemia discovered

New understanding of chronic myeloid leukemia

New understanding of chronic myeloid leukemia

More good Gleevec news

More good Gleevec news

Nilotinib and Dasatinib show promise as therapy for chronic myelogenous leukemia

Nilotinib and Dasatinib show promise as therapy for chronic myelogenous leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.